nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—Chlorthalidone—CA1—esophageal cancer	0.00664	0.307	CrCbGaD
Clonazepam—Chlorthalidone—CA2—esophageal cancer	0.00503	0.233	CrCbGaD
Clonazepam—Thrombophlebitis—Capecitabine—esophageal cancer	0.00248	0.00391	CcSEcCtD
Clonazepam—Sleep disorder—Capecitabine—esophageal cancer	0.00248	0.00391	CcSEcCtD
Clonazepam—Polyuria—Capecitabine—esophageal cancer	0.00245	0.00386	CcSEcCtD
Clonazepam—Skin discolouration—Methotrexate—esophageal cancer	0.00244	0.00385	CcSEcCtD
Clonazepam—Swelling—Capecitabine—esophageal cancer	0.00244	0.00384	CcSEcCtD
Clonazepam—Abdominal discomfort—Cisplatin—esophageal cancer	0.00242	0.00381	CcSEcCtD
Clonazepam—Herpes simplex—Methotrexate—esophageal cancer	0.00239	0.00377	CcSEcCtD
Clonazepam—Dysarthria—Methotrexate—esophageal cancer	0.00233	0.00367	CcSEcCtD
Clonazepam—Libido decreased—Capecitabine—esophageal cancer	0.00232	0.00365	CcSEcCtD
Clonazepam—Amnesia—Capecitabine—esophageal cancer	0.00229	0.0036	CcSEcCtD
Clonazepam—Increased appetite—Capecitabine—esophageal cancer	0.00229	0.0036	CcSEcCtD
Clonazepam—Inflammation—Methotrexate—esophageal cancer	0.00227	0.00358	CcSEcCtD
Clonazepam—Thirst—Capecitabine—esophageal cancer	0.00226	0.00356	CcSEcCtD
Clonazepam—Vaginal inflammation—Methotrexate—esophageal cancer	0.00221	0.00347	CcSEcCtD
Clonazepam—Neuropathy peripheral—Cisplatin—esophageal cancer	0.0022	0.00347	CcSEcCtD
Clonazepam—Cardiac failure—Capecitabine—esophageal cancer	0.0022	0.00347	CcSEcCtD
Clonazepam—Lethargy—Capecitabine—esophageal cancer	0.00219	0.00346	CcSEcCtD
Clonazepam—Cystitis noninfective—Methotrexate—esophageal cancer	0.00215	0.00339	CcSEcCtD
Clonazepam—Osteoarthritis—Capecitabine—esophageal cancer	0.00215	0.00339	CcSEcCtD
Clonazepam—Diplopia—Capecitabine—esophageal cancer	0.00215	0.00339	CcSEcCtD
Clonazepam—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00213	0.00336	CcSEcCtD
Clonazepam—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00213	0.00335	CcSEcCtD
Clonazepam—Cystitis—Methotrexate—esophageal cancer	0.00213	0.00335	CcSEcCtD
Clonazepam—Migraine—Capecitabine—esophageal cancer	0.00212	0.00333	CcSEcCtD
Clonazepam—Vaginal infection—Methotrexate—esophageal cancer	0.00208	0.00328	CcSEcCtD
Clonazepam—Face oedema—Capecitabine—esophageal cancer	0.00208	0.00327	CcSEcCtD
Clonazepam—Irritability—Capecitabine—esophageal cancer	0.00205	0.00323	CcSEcCtD
Clonazepam—Cardiac arrest—Capecitabine—esophageal cancer	0.00204	0.00322	CcSEcCtD
Clonazepam—Urinary retention—Capecitabine—esophageal cancer	0.00204	0.00322	CcSEcCtD
Clonazepam—Mood swings—Capecitabine—esophageal cancer	0.00204	0.00321	CcSEcCtD
Clonazepam—Ataxia—Capecitabine—esophageal cancer	0.00202	0.00318	CcSEcCtD
Clonazepam—Coma—Methotrexate—esophageal cancer	0.00201	0.00317	CcSEcCtD
Clonazepam—Dehydration—Capecitabine—esophageal cancer	0.002	0.00315	CcSEcCtD
Clonazepam—Urine output increased—Methotrexate—esophageal cancer	0.00199	0.00314	CcSEcCtD
Clonazepam—Bladder pain—Methotrexate—esophageal cancer	0.00199	0.00314	CcSEcCtD
Clonazepam—Urinary tract disorder—Cisplatin—esophageal cancer	0.00199	0.00314	CcSEcCtD
Clonazepam—Liver function test abnormal—Capecitabine—esophageal cancer	0.00199	0.00313	CcSEcCtD
Clonazepam—Connective tissue disorder—Cisplatin—esophageal cancer	0.00198	0.00312	CcSEcCtD
Clonazepam—Urethral disorder—Cisplatin—esophageal cancer	0.00198	0.00312	CcSEcCtD
Clonazepam—Gynaecomastia—Methotrexate—esophageal cancer	0.00197	0.00311	CcSEcCtD
Clonazepam—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00196	0.00309	CcSEcCtD
Clonazepam—Flunitrazepam—CYP2A6—esophageal cancer	0.00195	0.0899	CrCbGaD
Clonazepam—Visual impairment—Cisplatin—esophageal cancer	0.00194	0.00306	CcSEcCtD
Clonazepam—Breast disorder—Capecitabine—esophageal cancer	0.00194	0.00306	CcSEcCtD
Clonazepam—Nasopharyngitis—Capecitabine—esophageal cancer	0.00192	0.00303	CcSEcCtD
Clonazepam—Gastritis—Capecitabine—esophageal cancer	0.0019	0.003	CcSEcCtD
Clonazepam—Muscular weakness—Capecitabine—esophageal cancer	0.0019	0.00299	CcSEcCtD
Clonazepam—Eye disorder—Cisplatin—esophageal cancer	0.00189	0.00297	CcSEcCtD
Clonazepam—Lymphadenopathy—Methotrexate—esophageal cancer	0.00188	0.00296	CcSEcCtD
Clonazepam—Cardiac disorder—Cisplatin—esophageal cancer	0.00187	0.00295	CcSEcCtD
Clonazepam—Flushing—Cisplatin—esophageal cancer	0.00187	0.00295	CcSEcCtD
Clonazepam—Influenza—Capecitabine—esophageal cancer	0.00186	0.00293	CcSEcCtD
Clonazepam—Dysphagia—Capecitabine—esophageal cancer	0.00186	0.00293	CcSEcCtD
Clonazepam—Asthma—Capecitabine—esophageal cancer	0.00186	0.00293	CcSEcCtD
Clonazepam—Thrombophlebitis—Methotrexate—esophageal cancer	0.00185	0.00291	CcSEcCtD
Clonazepam—Polyuria—Methotrexate—esophageal cancer	0.00182	0.00287	CcSEcCtD
Clonazepam—Immune system disorder—Cisplatin—esophageal cancer	0.00182	0.00287	CcSEcCtD
Clonazepam—Bronchitis—Capecitabine—esophageal cancer	0.00179	0.00282	CcSEcCtD
Clonazepam—Alopecia—Cisplatin—esophageal cancer	0.00178	0.00281	CcSEcCtD
Clonazepam—Abdominal discomfort—Capecitabine—esophageal cancer	0.00178	0.00281	CcSEcCtD
Clonazepam—Malnutrition—Cisplatin—esophageal cancer	0.00176	0.00277	CcSEcCtD
Clonazepam—Dysuria—Capecitabine—esophageal cancer	0.00174	0.00274	CcSEcCtD
Clonazepam—Flatulence—Cisplatin—esophageal cancer	0.00173	0.00273	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00173	0.00272	CcSEcCtD
Clonazepam—Weight increased—Capecitabine—esophageal cancer	0.00169	0.00266	CcSEcCtD
Clonazepam—Visual disturbance—Methotrexate—esophageal cancer	0.00169	0.00266	CcSEcCtD
Clonazepam—Muscle spasms—Cisplatin—esophageal cancer	0.00169	0.00266	CcSEcCtD
Clonazepam—Weight decreased—Capecitabine—esophageal cancer	0.00168	0.00265	CcSEcCtD
Clonazepam—Pneumonia—Capecitabine—esophageal cancer	0.00167	0.00263	CcSEcCtD
Clonazepam—Vision blurred—Cisplatin—esophageal cancer	0.00166	0.00261	CcSEcCtD
Clonazepam—Depression—Capecitabine—esophageal cancer	0.00165	0.0026	CcSEcCtD
Clonazepam—Tremor—Cisplatin—esophageal cancer	0.00165	0.00259	CcSEcCtD
Clonazepam—Lethargy—Methotrexate—esophageal cancer	0.00163	0.00257	CcSEcCtD
Clonazepam—Ill-defined disorder—Cisplatin—esophageal cancer	0.00163	0.00257	CcSEcCtD
Clonazepam—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00162	0.00256	CcSEcCtD
Clonazepam—Anaemia—Cisplatin—esophageal cancer	0.00162	0.00256	CcSEcCtD
Clonazepam—Urinary tract infection—Capecitabine—esophageal cancer	0.00161	0.00254	CcSEcCtD
Clonazepam—Osteoarthritis—Methotrexate—esophageal cancer	0.0016	0.00252	CcSEcCtD
Clonazepam—Clozapine—CYP1B1—esophageal cancer	0.00159	0.0735	CrCbGaD
Clonazepam—Malaise—Cisplatin—esophageal cancer	0.00158	0.0025	CcSEcCtD
Clonazepam—Leukopenia—Cisplatin—esophageal cancer	0.00157	0.00248	CcSEcCtD
Clonazepam—Epistaxis—Capecitabine—esophageal cancer	0.00156	0.00246	CcSEcCtD
Clonazepam—Flurazepam—CYP2A6—esophageal cancer	0.00156	0.0722	CrCbGaD
Clonazepam—Irritability—Methotrexate—esophageal cancer	0.00153	0.00241	CcSEcCtD
Clonazepam—Mood swings—Methotrexate—esophageal cancer	0.00152	0.00239	CcSEcCtD
Clonazepam—Ataxia—Methotrexate—esophageal cancer	0.00151	0.00237	CcSEcCtD
Clonazepam—Myalgia—Cisplatin—esophageal cancer	0.0015	0.00236	CcSEcCtD
Clonazepam—Haemoglobin—Capecitabine—esophageal cancer	0.0015	0.00235	CcSEcCtD
Clonazepam—Rhinitis—Capecitabine—esophageal cancer	0.00149	0.00235	CcSEcCtD
Clonazepam—Anxiety—Cisplatin—esophageal cancer	0.00149	0.00235	CcSEcCtD
Clonazepam—Haemorrhage—Capecitabine—esophageal cancer	0.00149	0.00234	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00149	0.00234	CcSEcCtD
Clonazepam—Hypoaesthesia—Capecitabine—esophageal cancer	0.00148	0.00233	CcSEcCtD
Clonazepam—Liver function test abnormal—Methotrexate—esophageal cancer	0.00148	0.00233	CcSEcCtD
Clonazepam—Discomfort—Cisplatin—esophageal cancer	0.00148	0.00233	CcSEcCtD
Clonazepam—Pharyngitis—Capecitabine—esophageal cancer	0.00148	0.00233	CcSEcCtD
Clonazepam—Urinary tract disorder—Capecitabine—esophageal cancer	0.00147	0.00231	CcSEcCtD
Clonazepam—Oedema peripheral—Capecitabine—esophageal cancer	0.00147	0.00231	CcSEcCtD
Clonazepam—Connective tissue disorder—Capecitabine—esophageal cancer	0.00146	0.0023	CcSEcCtD
Clonazepam—Urethral disorder—Capecitabine—esophageal cancer	0.00146	0.0023	CcSEcCtD
Clonazepam—Breast disorder—Methotrexate—esophageal cancer	0.00145	0.00228	CcSEcCtD
Clonazepam—Anaphylactic shock—Cisplatin—esophageal cancer	0.00143	0.00226	CcSEcCtD
Clonazepam—Oedema—Cisplatin—esophageal cancer	0.00143	0.00226	CcSEcCtD
Clonazepam—Visual impairment—Capecitabine—esophageal cancer	0.00143	0.00226	CcSEcCtD
Clonazepam—Infection—Cisplatin—esophageal cancer	0.00142	0.00224	CcSEcCtD
Clonazepam—Nervous system disorder—Cisplatin—esophageal cancer	0.00141	0.00221	CcSEcCtD
Clonazepam—Thrombocytopenia—Cisplatin—esophageal cancer	0.0014	0.00221	CcSEcCtD
Clonazepam—Tachycardia—Cisplatin—esophageal cancer	0.0014	0.0022	CcSEcCtD
Clonazepam—Skin disorder—Cisplatin—esophageal cancer	0.00139	0.00219	CcSEcCtD
Clonazepam—Eye disorder—Capecitabine—esophageal cancer	0.00139	0.00219	CcSEcCtD
Clonazepam—Asthma—Methotrexate—esophageal cancer	0.00138	0.00218	CcSEcCtD
Clonazepam—Flushing—Capecitabine—esophageal cancer	0.00138	0.00217	CcSEcCtD
Clonazepam—Cardiac disorder—Capecitabine—esophageal cancer	0.00138	0.00217	CcSEcCtD
Clonazepam—Eosinophilia—Methotrexate—esophageal cancer	0.00137	0.00216	CcSEcCtD
Clonazepam—Anorexia—Cisplatin—esophageal cancer	0.00137	0.00215	CcSEcCtD
Clonazepam—Immune system disorder—Capecitabine—esophageal cancer	0.00134	0.00212	CcSEcCtD
Clonazepam—Hypotension—Cisplatin—esophageal cancer	0.00134	0.00211	CcSEcCtD
Clonazepam—Chills—Capecitabine—esophageal cancer	0.00133	0.0021	CcSEcCtD
Clonazepam—Abdominal discomfort—Methotrexate—esophageal cancer	0.00133	0.00209	CcSEcCtD
Clonazepam—Alopecia—Capecitabine—esophageal cancer	0.00131	0.00207	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00131	0.00206	CcSEcCtD
Clonazepam—Mental disorder—Capecitabine—esophageal cancer	0.0013	0.00205	CcSEcCtD
Clonazepam—Malnutrition—Capecitabine—esophageal cancer	0.00129	0.00204	CcSEcCtD
Clonazepam—Dysuria—Methotrexate—esophageal cancer	0.00129	0.00204	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00129	0.00203	CcSEcCtD
Clonazepam—Dyspnoea—Cisplatin—esophageal cancer	0.00128	0.00201	CcSEcCtD
Clonazepam—Flatulence—Capecitabine—esophageal cancer	0.00128	0.00201	CcSEcCtD
Clonazepam—Erectile dysfunction—Methotrexate—esophageal cancer	0.00127	0.00201	CcSEcCtD
Clonazepam—Back pain—Capecitabine—esophageal cancer	0.00125	0.00197	CcSEcCtD
Clonazepam—Decreased appetite—Cisplatin—esophageal cancer	0.00125	0.00196	CcSEcCtD
Clonazepam—Muscle spasms—Capecitabine—esophageal cancer	0.00124	0.00196	CcSEcCtD
Clonazepam—Pneumonia—Methotrexate—esophageal cancer	0.00124	0.00195	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00124	0.00195	CcSEcCtD
Clonazepam—Drowsiness—Methotrexate—esophageal cancer	0.00123	0.00194	CcSEcCtD
Clonazepam—Depression—Methotrexate—esophageal cancer	0.00123	0.00194	CcSEcCtD
Clonazepam—Pain—Cisplatin—esophageal cancer	0.00123	0.00193	CcSEcCtD
Clonazepam—Clozapine—CYP2A6—esophageal cancer	0.00122	0.0566	CrCbGaD
Clonazepam—Vision blurred—Capecitabine—esophageal cancer	0.00122	0.00192	CcSEcCtD
Clonazepam—Tremor—Capecitabine—esophageal cancer	0.00121	0.00191	CcSEcCtD
Clonazepam—Ill-defined disorder—Capecitabine—esophageal cancer	0.0012	0.00189	CcSEcCtD
Clonazepam—Anaemia—Capecitabine—esophageal cancer	0.0012	0.00189	CcSEcCtD
Clonazepam—Feeling abnormal—Cisplatin—esophageal cancer	0.00118	0.00186	CcSEcCtD
Clonazepam—Malaise—Capecitabine—esophageal cancer	0.00117	0.00184	CcSEcCtD
Clonazepam—Epistaxis—Methotrexate—esophageal cancer	0.00116	0.00183	CcSEcCtD
Clonazepam—Vertigo—Capecitabine—esophageal cancer	0.00116	0.00183	CcSEcCtD
Clonazepam—Leukopenia—Capecitabine—esophageal cancer	0.00116	0.00183	CcSEcCtD
Clonazepam—Palpitations—Capecitabine—esophageal cancer	0.00114	0.0018	CcSEcCtD
Clonazepam—Body temperature increased—Cisplatin—esophageal cancer	0.00113	0.00179	CcSEcCtD
Clonazepam—Cough—Capecitabine—esophageal cancer	0.00113	0.00178	CcSEcCtD
Clonazepam—Haemoglobin—Methotrexate—esophageal cancer	0.00111	0.00175	CcSEcCtD
Clonazepam—Haemorrhage—Methotrexate—esophageal cancer	0.00111	0.00174	CcSEcCtD
Clonazepam—Myalgia—Capecitabine—esophageal cancer	0.0011	0.00174	CcSEcCtD
Clonazepam—Arthralgia—Capecitabine—esophageal cancer	0.0011	0.00174	CcSEcCtD
Clonazepam—Chest pain—Capecitabine—esophageal cancer	0.0011	0.00174	CcSEcCtD
Clonazepam—Pharyngitis—Methotrexate—esophageal cancer	0.0011	0.00173	CcSEcCtD
Clonazepam—Anxiety—Capecitabine—esophageal cancer	0.0011	0.00173	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00109	0.00172	CcSEcCtD
Clonazepam—Urinary tract disorder—Methotrexate—esophageal cancer	0.00109	0.00172	CcSEcCtD
Clonazepam—Discomfort—Capecitabine—esophageal cancer	0.00109	0.00172	CcSEcCtD
Clonazepam—Urethral disorder—Methotrexate—esophageal cancer	0.00109	0.00171	CcSEcCtD
Clonazepam—Dry mouth—Capecitabine—esophageal cancer	0.00108	0.0017	CcSEcCtD
Clonazepam—Visual impairment—Methotrexate—esophageal cancer	0.00107	0.00168	CcSEcCtD
Clonazepam—Confusional state—Capecitabine—esophageal cancer	0.00107	0.00168	CcSEcCtD
Clonazepam—Oedema—Capecitabine—esophageal cancer	0.00106	0.00166	CcSEcCtD
Clonazepam—Hypersensitivity—Cisplatin—esophageal cancer	0.00106	0.00166	CcSEcCtD
Clonazepam—Infection—Capecitabine—esophageal cancer	0.00105	0.00165	CcSEcCtD
Clonazepam—Nervous system disorder—Capecitabine—esophageal cancer	0.00104	0.00163	CcSEcCtD
Clonazepam—Eye disorder—Methotrexate—esophageal cancer	0.00103	0.00163	CcSEcCtD
Clonazepam—Thrombocytopenia—Capecitabine—esophageal cancer	0.00103	0.00163	CcSEcCtD
Clonazepam—Tachycardia—Capecitabine—esophageal cancer	0.00103	0.00162	CcSEcCtD
Clonazepam—Asthenia—Cisplatin—esophageal cancer	0.00103	0.00162	CcSEcCtD
Clonazepam—Cardiac disorder—Methotrexate—esophageal cancer	0.00103	0.00162	CcSEcCtD
Clonazepam—Skin disorder—Capecitabine—esophageal cancer	0.00103	0.00162	CcSEcCtD
Clonazepam—Anorexia—Capecitabine—esophageal cancer	0.00101	0.00159	CcSEcCtD
Clonazepam—Immune system disorder—Methotrexate—esophageal cancer	0.001	0.00158	CcSEcCtD
Clonazepam—Chills—Methotrexate—esophageal cancer	0.000994	0.00157	CcSEcCtD
Clonazepam—Hypotension—Capecitabine—esophageal cancer	0.000988	0.00156	CcSEcCtD
Clonazepam—Diarrhoea—Cisplatin—esophageal cancer	0.000981	0.00155	CcSEcCtD
Clonazepam—Alopecia—Methotrexate—esophageal cancer	0.000979	0.00154	CcSEcCtD
Clonazepam—Mental disorder—Methotrexate—esophageal cancer	0.00097	0.00153	CcSEcCtD
Clonazepam—Malnutrition—Methotrexate—esophageal cancer	0.000964	0.00152	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000963	0.00152	CcSEcCtD
Clonazepam—Insomnia—Capecitabine—esophageal cancer	0.000956	0.00151	CcSEcCtD
Clonazepam—Diazepam—PTGS1—esophageal cancer	0.00095	0.0439	CrCbGaD
Clonazepam—Dyspnoea—Capecitabine—esophageal cancer	0.000942	0.00148	CcSEcCtD
Clonazepam—Back pain—Methotrexate—esophageal cancer	0.000932	0.00147	CcSEcCtD
Clonazepam—Dyspepsia—Capecitabine—esophageal cancer	0.00093	0.00147	CcSEcCtD
Clonazepam—Decreased appetite—Capecitabine—esophageal cancer	0.000919	0.00145	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000912	0.00144	CcSEcCtD
Clonazepam—Vomiting—Cisplatin—esophageal cancer	0.000912	0.00144	CcSEcCtD
Clonazepam—Fatigue—Capecitabine—esophageal cancer	0.000911	0.00144	CcSEcCtD
Clonazepam—Vision blurred—Methotrexate—esophageal cancer	0.000908	0.00143	CcSEcCtD
Clonazepam—Rash—Cisplatin—esophageal cancer	0.000904	0.00142	CcSEcCtD
Clonazepam—Pain—Capecitabine—esophageal cancer	0.000904	0.00142	CcSEcCtD
Clonazepam—Constipation—Capecitabine—esophageal cancer	0.000904	0.00142	CcSEcCtD
Clonazepam—Dermatitis—Cisplatin—esophageal cancer	0.000903	0.00142	CcSEcCtD
Clonazepam—Ill-defined disorder—Methotrexate—esophageal cancer	0.000894	0.00141	CcSEcCtD
Clonazepam—Anaemia—Methotrexate—esophageal cancer	0.000891	0.0014	CcSEcCtD
Clonazepam—Feeling abnormal—Capecitabine—esophageal cancer	0.000871	0.00137	CcSEcCtD
Clonazepam—Malaise—Methotrexate—esophageal cancer	0.000869	0.00137	CcSEcCtD
Clonazepam—Vertigo—Methotrexate—esophageal cancer	0.000866	0.00136	CcSEcCtD
Clonazepam—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000864	0.00136	CcSEcCtD
Clonazepam—Leukopenia—Methotrexate—esophageal cancer	0.000863	0.00136	CcSEcCtD
Clonazepam—Nausea—Cisplatin—esophageal cancer	0.000852	0.00134	CcSEcCtD
Clonazepam—Cough—Methotrexate—esophageal cancer	0.000841	0.00132	CcSEcCtD
Clonazepam—Urticaria—Capecitabine—esophageal cancer	0.00084	0.00132	CcSEcCtD
Clonazepam—Body temperature increased—Capecitabine—esophageal cancer	0.000835	0.00132	CcSEcCtD
Clonazepam—Abdominal pain—Capecitabine—esophageal cancer	0.000835	0.00132	CcSEcCtD
Clonazepam—Arthralgia—Methotrexate—esophageal cancer	0.000821	0.00129	CcSEcCtD
Clonazepam—Chest pain—Methotrexate—esophageal cancer	0.000821	0.00129	CcSEcCtD
Clonazepam—Myalgia—Methotrexate—esophageal cancer	0.000821	0.00129	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000815	0.00128	CcSEcCtD
Clonazepam—Discomfort—Methotrexate—esophageal cancer	0.000811	0.00128	CcSEcCtD
Clonazepam—Confusional state—Methotrexate—esophageal cancer	0.000793	0.00125	CcSEcCtD
Clonazepam—Anaphylactic shock—Methotrexate—esophageal cancer	0.000787	0.00124	CcSEcCtD
Clonazepam—Infection—Methotrexate—esophageal cancer	0.000782	0.00123	CcSEcCtD
Clonazepam—Hypersensitivity—Capecitabine—esophageal cancer	0.000779	0.00123	CcSEcCtD
Clonazepam—Nervous system disorder—Methotrexate—esophageal cancer	0.000772	0.00122	CcSEcCtD
Clonazepam—Thrombocytopenia—Methotrexate—esophageal cancer	0.00077	0.00121	CcSEcCtD
Clonazepam—Skin disorder—Methotrexate—esophageal cancer	0.000764	0.0012	CcSEcCtD
Clonazepam—Asthenia—Capecitabine—esophageal cancer	0.000758	0.00119	CcSEcCtD
Clonazepam—Anorexia—Methotrexate—esophageal cancer	0.00075	0.00118	CcSEcCtD
Clonazepam—Pruritus—Capecitabine—esophageal cancer	0.000748	0.00118	CcSEcCtD
Clonazepam—Hypotension—Methotrexate—esophageal cancer	0.000735	0.00116	CcSEcCtD
Clonazepam—Diarrhoea—Capecitabine—esophageal cancer	0.000723	0.00114	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000717	0.00113	CcSEcCtD
Clonazepam—Insomnia—Methotrexate—esophageal cancer	0.000712	0.00112	CcSEcCtD
Clonazepam—Dyspnoea—Methotrexate—esophageal cancer	0.000701	0.0011	CcSEcCtD
Clonazepam—Somnolence—Methotrexate—esophageal cancer	0.000699	0.0011	CcSEcCtD
Clonazepam—Dizziness—Capecitabine—esophageal cancer	0.000699	0.0011	CcSEcCtD
Clonazepam—Dyspepsia—Methotrexate—esophageal cancer	0.000693	0.00109	CcSEcCtD
Clonazepam—Decreased appetite—Methotrexate—esophageal cancer	0.000684	0.00108	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000679	0.00107	CcSEcCtD
Clonazepam—Fatigue—Methotrexate—esophageal cancer	0.000678	0.00107	CcSEcCtD
Clonazepam—Pain—Methotrexate—esophageal cancer	0.000673	0.00106	CcSEcCtD
Clonazepam—Vomiting—Capecitabine—esophageal cancer	0.000672	0.00106	CcSEcCtD
Clonazepam—Rash—Capecitabine—esophageal cancer	0.000666	0.00105	CcSEcCtD
Clonazepam—Dermatitis—Capecitabine—esophageal cancer	0.000666	0.00105	CcSEcCtD
Clonazepam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000664	0.00193	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000663	0.00193	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000663	0.00193	CbGpPWpGaD
Clonazepam—Headache—Capecitabine—esophageal cancer	0.000662	0.00104	CcSEcCtD
Clonazepam—Nitrazepam—ABCB1—esophageal cancer	0.000654	0.0302	CrCbGaD
Clonazepam—NAT2—Metabolism—TYMP—esophageal cancer	0.000653	0.0019	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—GNG7—esophageal cancer	0.00065	0.00189	CbGpPWpGaD
Clonazepam—Feeling abnormal—Methotrexate—esophageal cancer	0.000648	0.00102	CcSEcCtD
Clonazepam—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000643	0.00101	CcSEcCtD
Clonazepam—GABRG2—Orphan transporters—CREBBP—esophageal cancer	0.00064	0.00186	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP26A1—esophageal cancer	0.000635	0.00185	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000635	0.00185	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000635	0.00185	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000635	0.00185	CbGpPWpGaD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000632	0.00184	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000632	0.00184	CbGpPWpGaD
Clonazepam—Nausea—Capecitabine—esophageal cancer	0.000628	0.000989	CcSEcCtD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000626	0.00182	CbGpPWpGaD
Clonazepam—Urticaria—Methotrexate—esophageal cancer	0.000625	0.000984	CcSEcCtD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000623	0.00181	CbGpPWpGaD
Clonazepam—Body temperature increased—Methotrexate—esophageal cancer	0.000622	0.00098	CcSEcCtD
Clonazepam—Abdominal pain—Methotrexate—esophageal cancer	0.000622	0.00098	CcSEcCtD
Clonazepam—NAT2—Metabolism—ALOX15—esophageal cancer	0.000619	0.0018	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—ALDH2—esophageal cancer	0.000609	0.00177	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000606	0.00176	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000606	0.00176	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000606	0.00176	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000605	0.00176	CbGpPWpGaD
Clonazepam—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000603	0.00176	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—ALDH2—esophageal cancer	0.000597	0.00174	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000597	0.00174	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—TPI1—esophageal cancer	0.000591	0.00172	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTO1—esophageal cancer	0.000591	0.00172	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PFN1—esophageal cancer	0.000587	0.00171	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000586	0.00171	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CAPZA1—esophageal cancer	0.000585	0.0017	CbGpPWpGaD
Clonazepam—Flurazepam—ABCB1—esophageal cancer	0.000581	0.0269	CrCbGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000581	0.00169	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000581	0.00169	CbGpPWpGaD
Clonazepam—Hypersensitivity—Methotrexate—esophageal cancer	0.00058	0.000913	CcSEcCtD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000572	0.00167	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTT1—esophageal cancer	0.000568	0.00165	CbGpPWpGaD
Clonazepam—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000567	0.00165	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ALDOB—esophageal cancer	0.000566	0.00165	CbGpPWpGaD
Clonazepam—Asthenia—Methotrexate—esophageal cancer	0.000564	0.000889	CcSEcCtD
Clonazepam—CYP2E1—Biological oxidations—CYP2A6—esophageal cancer	0.000561	0.00163	CbGpPWpGaD
Clonazepam—GABRA1—Orphan transporters—CREBBP—esophageal cancer	0.000559	0.00163	CbGpPWpGaD
Clonazepam—Pruritus—Methotrexate—esophageal cancer	0.000557	0.000877	CcSEcCtD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000555	0.00162	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GAPDH—esophageal cancer	0.000545	0.00159	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CRABP1—esophageal cancer	0.00054	0.00157	CbGpPWpGaD
Clonazepam—Midazolam—ABCB1—esophageal cancer	0.000539	0.0249	CrCbGaD
Clonazepam—Diarrhoea—Methotrexate—esophageal cancer	0.000538	0.000848	CcSEcCtD
Clonazepam—ALB—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000533	0.00155	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—PTGS1—esophageal cancer	0.000532	0.00155	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00053	0.00154	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000521	0.00152	CbGpPWpGaD
Clonazepam—Dizziness—Methotrexate—esophageal cancer	0.00052	0.000819	CcSEcCtD
Clonazepam—NAT2—Metabolism—GNG7—esophageal cancer	0.000514	0.0015	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000508	0.00148	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000508	0.00148	CbGpPWpGaD
Clonazepam—Vomiting—Methotrexate—esophageal cancer	0.0005	0.000788	CcSEcCtD
Clonazepam—Rash—Methotrexate—esophageal cancer	0.000496	0.000781	CcSEcCtD
Clonazepam—Dermatitis—Methotrexate—esophageal cancer	0.000496	0.000781	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000495	0.00144	CbGpPWpGaD
Clonazepam—Headache—Methotrexate—esophageal cancer	0.000493	0.000776	CcSEcCtD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00049	0.00143	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000487	0.00142	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ALDH2—esophageal cancer	0.000482	0.0014	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000481	0.0014	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000481	0.0014	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—CFL1—esophageal cancer	0.000475	0.00138	CbGpPWpGaD
Clonazepam—Nausea—Methotrexate—esophageal cancer	0.000467	0.000736	CcSEcCtD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000465	0.00135	CbGpPWpGaD
Clonazepam—Diazepam—ABCB1—esophageal cancer	0.000462	0.0214	CrCbGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000459	0.00134	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000458	0.00133	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTT1—esophageal cancer	0.000458	0.00133	CbGpPWpGaD
Clonazepam—Clozapine—ABCB1—esophageal cancer	0.000456	0.0211	CrCbGaD
Clonazepam—NAT2—Metabolism—CYP2A6—esophageal cancer	0.000453	0.00132	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP1B1—esophageal cancer	0.000452	0.00132	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000452	0.00132	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000448	0.00131	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—GNG7—esophageal cancer	0.000448	0.0013	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000446	0.0013	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00044	0.00128	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000437	0.00127	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ENO1—esophageal cancer	0.000429	0.00125	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS1—esophageal cancer	0.000429	0.00125	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP19A1—esophageal cancer	0.000425	0.00124	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PSME1—esophageal cancer	0.000423	0.00123	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PSME2—esophageal cancer	0.000423	0.00123	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00042	0.00122	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000417	0.00121	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000404	0.00118	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.0004	0.00116	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000395	0.00115	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000393	0.00114	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ATP1B2—esophageal cancer	0.000387	0.00113	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000385	0.00112	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000375	0.00109	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000372	0.00108	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000365	0.00106	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—HSPA5—esophageal cancer	0.000365	0.00106	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP1B1—esophageal cancer	0.000365	0.00106	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00036	0.00105	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000357	0.00104	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—DOCK2—esophageal cancer	0.00035	0.00102	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000349	0.00102	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP19A1—esophageal cancer	0.000343	0.000999	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.00034	0.000989	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000335	0.000976	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000335	0.000976	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000318	0.000925	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—HMOX1—esophageal cancer	0.000313	0.000912	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000303	0.000883	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PFN1—esophageal cancer	0.000302	0.00088	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ABCB1—esophageal cancer	0.000301	0.000875	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—PTGS2—esophageal cancer	0.0003	0.000872	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000291	0.000846	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000291	0.000846	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000277	0.000806	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000275	0.000801	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000266	0.000775	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000263	0.000767	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.00026	0.000758	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000255	0.000744	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000254	0.000739	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000253	0.000738	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000247	0.000719	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CFL1—esophageal cancer	0.000245	0.000713	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000244	0.00071	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000243	0.000709	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000234	0.00068	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—GNG7—esophageal cancer	0.000231	0.000672	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC52A3—esophageal cancer	0.000229	0.000665	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—BLVRB—esophageal cancer	0.000229	0.000665	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TP53—esophageal cancer	0.000224	0.000653	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000221	0.000644	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00022	0.000641	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000213	0.000619	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.00021	0.000611	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000207	0.000603	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000204	0.000595	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CREBBP—esophageal cancer	0.000201	0.000585	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.0002	0.000582	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000197	0.000575	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC52A3—esophageal cancer	0.000196	0.000572	CbGpPWpGaD
Clonazepam—ALB—Metabolism—BLVRB—esophageal cancer	0.000196	0.000572	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000195	0.000567	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC10A2—esophageal cancer	0.000194	0.000566	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CA1—esophageal cancer	0.000194	0.000566	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—HSPA5—esophageal cancer	0.000188	0.000548	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NOS3—esophageal cancer	0.00018	0.000524	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CA2—esophageal cancer	0.000178	0.000517	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000176	0.000511	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000171	0.000497	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CA1—esophageal cancer	0.000167	0.000486	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC10A2—esophageal cancer	0.000167	0.000486	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ADH7—esophageal cancer	0.000165	0.000481	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PLCE1—esophageal cancer	0.000165	0.000481	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS2—esophageal cancer	0.000164	0.000479	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000163	0.000474	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000156	0.000455	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CA2—esophageal cancer	0.000153	0.000445	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000149	0.000435	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ADH1B—esophageal cancer	0.000145	0.000422	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PLCE1—esophageal cancer	0.000142	0.000413	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ADH7—esophageal cancer	0.000142	0.000413	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00014	0.000409	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ABL1—esophageal cancer	0.000139	0.000406	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TYMP—esophageal cancer	0.000138	0.000403	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—EP300—esophageal cancer	0.000137	0.000398	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000137	0.000397	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP26A1—esophageal cancer	0.000135	0.000392	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ALOX15—esophageal cancer	0.000131	0.000382	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTO1—esophageal cancer	0.000125	0.000365	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—TPI1—esophageal cancer	0.000125	0.000365	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ADH1B—esophageal cancer	0.000125	0.000363	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000122	0.000355	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ALDOB—esophageal cancer	0.00012	0.00035	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TYMP—esophageal cancer	0.000119	0.000346	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000117	0.00034	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP26A1—esophageal cancer	0.000116	0.000337	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GAPDH—esophageal cancer	0.000116	0.000336	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CRABP1—esophageal cancer	0.000115	0.000333	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ALOX15—esophageal cancer	0.000113	0.000328	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GNG7—esophageal cancer	0.000109	0.000317	CbGpPWpGaD
Clonazepam—ALB—Metabolism—TPI1—esophageal cancer	0.000108	0.000313	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTO1—esophageal cancer	0.000108	0.000313	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000106	0.000309	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000106	0.000309	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ALDOB—esophageal cancer	0.000103	0.0003	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ALDH2—esophageal cancer	0.000102	0.000297	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CA—esophageal cancer	0.000101	0.000295	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—NOS2—esophageal cancer	0.000101	0.000293	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GAPDH—esophageal cancer	9.93e-05	0.000289	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CRABP1—esophageal cancer	9.84e-05	0.000287	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTT1—esophageal cancer	9.71e-05	0.000283	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP2A6—esophageal cancer	9.6e-05	0.000279	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GNG7—esophageal cancer	9.36e-05	0.000273	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS1—esophageal cancer	9.1e-05	0.000265	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ENO1—esophageal cancer	9.1e-05	0.000265	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—CREBBP—esophageal cancer	9.03e-05	0.000263	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CA1—esophageal cancer	9.02e-05	0.000263	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.02e-05	0.000263	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PSME1—esophageal cancer	8.97e-05	0.000261	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PSME2—esophageal cancer	8.97e-05	0.000261	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	8.82e-05	0.000257	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ALDH2—esophageal cancer	8.77e-05	0.000255	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTT1—esophageal cancer	8.35e-05	0.000243	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP2A6—esophageal cancer	8.25e-05	0.00024	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CA2—esophageal cancer	8.25e-05	0.00024	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.22e-05	0.000239	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—NOS3—esophageal cancer	8.08e-05	0.000235	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ENO1—esophageal cancer	7.82e-05	0.000228	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS1—esophageal cancer	7.82e-05	0.000228	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.81e-05	0.000227	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP1B1—esophageal cancer	7.74e-05	0.000225	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PSME1—esophageal cancer	7.71e-05	0.000224	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PSME2—esophageal cancer	7.71e-05	0.000224	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ADH7—esophageal cancer	7.67e-05	0.000223	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.67e-05	0.000223	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP19A1—esophageal cancer	7.27e-05	0.000212	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.73e-05	0.000196	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.72e-05	0.000196	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP1B1—esophageal cancer	6.65e-05	0.000194	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—HMOX1—esophageal cancer	6.64e-05	0.000193	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TYMP—esophageal cancer	6.42e-05	0.000187	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ABCB1—esophageal cancer	6.37e-05	0.000185	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP19A1—esophageal cancer	6.25e-05	0.000182	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.25e-05	0.000182	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—EP300—esophageal cancer	6.15e-05	0.000179	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.09e-05	0.000177	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.81e-05	0.000169	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—TPI1—esophageal cancer	5.81e-05	0.000169	CbGpPWpGaD
Clonazepam—ALB—Metabolism—HMOX1—esophageal cancer	5.71e-05	0.000166	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.6e-05	0.000163	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.57e-05	0.000162	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ABCB1—esophageal cancer	5.48e-05	0.000159	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.36e-05	0.000156	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.31e-05	0.000155	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GNG7—esophageal cancer	5.05e-05	0.000147	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.74e-05	0.000138	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CA—esophageal cancer	4.55e-05	0.000132	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.51e-05	0.000131	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.45e-05	0.00013	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TP53—esophageal cancer	4.4e-05	0.000128	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CREBBP—esophageal cancer	4.26e-05	0.000124	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ENO1—esophageal cancer	4.22e-05	0.000123	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.22e-05	0.000123	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PSME2—esophageal cancer	4.16e-05	0.000121	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PSME1—esophageal cancer	4.16e-05	0.000121	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.14e-05	0.000121	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NOS3—esophageal cancer	3.81e-05	0.000111	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CREBBP—esophageal cancer	3.66e-05	0.000107	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.59e-05	0.000105	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS2—esophageal cancer	3.49e-05	0.000102	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.37e-05	9.83e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NOS3—esophageal cancer	3.28e-05	9.54e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.08e-05	8.97e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS2—esophageal cancer	3e-05	8.72e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.96e-05	8.61e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—EP300—esophageal cancer	2.9e-05	8.44e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—EP300—esophageal cancer	2.49e-05	7.26e-05	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CA—esophageal cancer	2.15e-05	6.25e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.98e-05	5.75e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CA—esophageal cancer	1.84e-05	5.37e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NOS3—esophageal cancer	1.77e-05	5.15e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.62e-05	4.71e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—EP300—esophageal cancer	1.35e-05	3.92e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.95e-06	2.9e-05	CbGpPWpGaD
